Recenti acquisizioni sulla neurobiologia della depressione maggiore: Una revisione critica

Translated title of the contribution: Recent assessments on the neurobiology of major depression: A critical review

Research output: Contribution to journalArticle

Abstract

In the last decade, considerable progress has been made toward the identification of the main neurobiological mechanisms of depression and, even though abnormalities in the levels and functions of the neurotransmitters serotonin, norepinephrine and dopamine are well-established, substantial evidence indicates that not only monoamines play an important role in the pathophisiology of depression. Symptoms and signs of depression seem to be associated in changes in neurotransmitter function, neuroendocrine and immune status. Continuous advances in the neurobiology of these systems in depression will undoubtedly see in the near future the arrival of new classes of antidepressant drugs such as corticotropin-releasing factors antagonists, substance P antagonists, vasopressin-receptor antagonists, etc. Therefore, although it remains to be seen whether alterations in neurotransmitters and neurohormones represent the cause or the consequence of depressive illness, it is of great clinical interest to update the neurobiological background of depressive illness with more recent assessments in the field in terms of psychopharmacology and treatment options.

Original languageItalian
Pages (from-to)185-207
Number of pages23
JournalRivista di Psichiatria
Volume43
Issue number4
Publication statusPublished - Jul 2008

Fingerprint

Neurobiology
Neurotransmitter Agents
Depression
Psychopharmacology
Corticotropin-Releasing Hormone
Substance P
Antidepressive Agents
Signs and Symptoms
Dopamine
Serotonin
Norepinephrine

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Recenti acquisizioni sulla neurobiologia della depressione maggiore : Una revisione critica. / Altamura, Alfredo Carlo; Dell'Osso, Bernardo; Serati, Marta; Ciabatti, Mariateresa; Buoli, Massimiliano.

In: Rivista di Psichiatria, Vol. 43, No. 4, 07.2008, p. 185-207.

Research output: Contribution to journalArticle

@article{890f8caea3e349e593fce87f35a21532,
title = "Recenti acquisizioni sulla neurobiologia della depressione maggiore: Una revisione critica",
abstract = "In the last decade, considerable progress has been made toward the identification of the main neurobiological mechanisms of depression and, even though abnormalities in the levels and functions of the neurotransmitters serotonin, norepinephrine and dopamine are well-established, substantial evidence indicates that not only monoamines play an important role in the pathophisiology of depression. Symptoms and signs of depression seem to be associated in changes in neurotransmitter function, neuroendocrine and immune status. Continuous advances in the neurobiology of these systems in depression will undoubtedly see in the near future the arrival of new classes of antidepressant drugs such as corticotropin-releasing factors antagonists, substance P antagonists, vasopressin-receptor antagonists, etc. Therefore, although it remains to be seen whether alterations in neurotransmitters and neurohormones represent the cause or the consequence of depressive illness, it is of great clinical interest to update the neurobiological background of depressive illness with more recent assessments in the field in terms of psychopharmacology and treatment options.",
keywords = "Immune system, Major depression, Neurobiology, Neuroendocrine system, Neurotransmitters abnormalities",
author = "Altamura, {Alfredo Carlo} and Bernardo Dell'Osso and Marta Serati and Mariateresa Ciabatti and Massimiliano Buoli",
year = "2008",
month = "7",
language = "Italian",
volume = "43",
pages = "185--207",
journal = "Rivista di Psichiatria",
issn = "0035-6484",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "4",

}

TY - JOUR

T1 - Recenti acquisizioni sulla neurobiologia della depressione maggiore

T2 - Una revisione critica

AU - Altamura, Alfredo Carlo

AU - Dell'Osso, Bernardo

AU - Serati, Marta

AU - Ciabatti, Mariateresa

AU - Buoli, Massimiliano

PY - 2008/7

Y1 - 2008/7

N2 - In the last decade, considerable progress has been made toward the identification of the main neurobiological mechanisms of depression and, even though abnormalities in the levels and functions of the neurotransmitters serotonin, norepinephrine and dopamine are well-established, substantial evidence indicates that not only monoamines play an important role in the pathophisiology of depression. Symptoms and signs of depression seem to be associated in changes in neurotransmitter function, neuroendocrine and immune status. Continuous advances in the neurobiology of these systems in depression will undoubtedly see in the near future the arrival of new classes of antidepressant drugs such as corticotropin-releasing factors antagonists, substance P antagonists, vasopressin-receptor antagonists, etc. Therefore, although it remains to be seen whether alterations in neurotransmitters and neurohormones represent the cause or the consequence of depressive illness, it is of great clinical interest to update the neurobiological background of depressive illness with more recent assessments in the field in terms of psychopharmacology and treatment options.

AB - In the last decade, considerable progress has been made toward the identification of the main neurobiological mechanisms of depression and, even though abnormalities in the levels and functions of the neurotransmitters serotonin, norepinephrine and dopamine are well-established, substantial evidence indicates that not only monoamines play an important role in the pathophisiology of depression. Symptoms and signs of depression seem to be associated in changes in neurotransmitter function, neuroendocrine and immune status. Continuous advances in the neurobiology of these systems in depression will undoubtedly see in the near future the arrival of new classes of antidepressant drugs such as corticotropin-releasing factors antagonists, substance P antagonists, vasopressin-receptor antagonists, etc. Therefore, although it remains to be seen whether alterations in neurotransmitters and neurohormones represent the cause or the consequence of depressive illness, it is of great clinical interest to update the neurobiological background of depressive illness with more recent assessments in the field in terms of psychopharmacology and treatment options.

KW - Immune system

KW - Major depression

KW - Neurobiology

KW - Neuroendocrine system

KW - Neurotransmitters abnormalities

UR - http://www.scopus.com/inward/record.url?scp=48249116462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48249116462&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:48249116462

VL - 43

SP - 185

EP - 207

JO - Rivista di Psichiatria

JF - Rivista di Psichiatria

SN - 0035-6484

IS - 4

ER -